NSC |
Compound |
Enrichment |
Correlation |
NSC 679240 |
Null |
0.029142074732756 |
0.21303261 |
NSC 709358 |
1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol |
0.029142074732756 |
0.26708052 |
NSC 717468 |
Null |
0.029142074732756 |
0.14191224 |
NSC 731701 |
1[(4-n-butyloxyCarbonyl)piperazine-1-yl]diazene-1-ium-1,2-di olate |
0.029142074732756 |
-0.23670116 |
NSC 734141 |
6-(3-Aminopropyl)-5,6-dihydro-8,9-dimethoxy-3-nitro-5,11-dio xo-11H-indeno[1,2-c]isoquinoline Hydrochloride |
0.029142074732756 |
0.33172126 |
NSC 756401 |
GW832467X |
0.029142074732756 |
-0.22415161 |
NSC 275656 |
m-Dioxane-5-methanol, 2,2-dimethyl-5-(4,6-diaziridinyl-2-S-triazinylamino)- |
0.0295480456086945 |
0.46229309 |
NSC 329250 |
Null |
0.0295480456086945 |
0.25729468 |
NSC 357704 |
Cyanomorpholinodoxorubicin |
0.0295480456086945 |
0.52630097 |
NSC 381867 |
BAFILOMYCIN ANTIBIOTIC |
0.0295480456086945 |
0.19692197 |